A study investigating the effects of an adapted Qigong exercise programme in patients suffering from chronic low back pain

ISRCTN ISRCTN15963005
DOI https://doi.org/10.1186/ISRCTN15963005
Submission date
18/06/2024
Registration date
02/07/2024
Last edited
02/07/2024
Recruitment status
No longer recruiting
Overall study status
Ongoing
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Non-specific chronic low back pain is a common musculoskeletal condition with very high direct and indirect costs in health systems globally. Furthermore, it is linked with several comorbidities such as depression, anxiety, sleep disorders, and kinesiophobia and has been linked with considerable functional disability. Evidence suggests that Qigong exercise plays a beneficial role in the treatment of chronic low back pain. However, there is still a limited number of studies investigating the effects of Qigong on parameters and comorbidities that exist in this population and comparing Qigong with other treatment methods. The main hypothesis of this study is that the addition of a Qigong exercise routine will be superior to the addition of stretching exercises or no exercises on standardised acupuncture treatment.

Who can participate?
Adults aged between 18 and 65 years old with pain in their lower back for more than three months and have been previously diagnosed with non-specific chronic lower back pain

What does the study involve?
Participants will be randomly allocated to three groups. In all the groups, participants will receive acupuncture as a baseline treatment and either receive no other treatment, supervised and home-based stretching exercises or supervised and home-based Qigong exercises.

What are the possible benefits and risks of participating?
The benefits of participating in this study are pain reduction, improvement in functionality, and psychosocial factors commonly linked with the disease. Acupuncture and exercise techniques have a very good safety record and adverse events are extremely rare.

Where is the study run from?
University of West Attica, Greece

When is the study starting and how long is it expected to run for?
January 2020 to December 2025

Who is funding the study?
1. Investigator initiated and funded
2. University of West Attica, Greece

Who is the main contact?
Spyridon Sotiropoulos, spiros_sotiropoylos@hotmail.com

Contact information

Mr Spyridon Sotiropoulos
Public, Scientific, Principal Investigator

8 Sisini Str
Athens
11528
Greece

ORCiD logoORCID ID 0009-0003-8403-4610
Phone +306944331852
Email ssotiropoulos@uniwa.gr
Mr Spyridon Sotiropoulos
Public

8 Sisini Str
Athens
11528
Greece

Phone +306944331852
Email spiros_sotiropoylos@hotmail.com

Study information

Study designInterventional double-blind randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Home, Hospital, University/medical school/dental school
Study typeTreatment
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleA randomised control trial comparing the effects of acupuncture combined with an add on Qigong programme, to acupuncture as a stand alone treatment and acupuncture combined with stretching exercises, in terms of pain, proprioception, functionality and psychosocial comorbidities.
Study hypothesisParticipants allocated in the group receiving the add-on program of adapted Qigong exercises will show statistically significant differences compared to the group who will follow usual exercises with stretching and in the acupuncture group, regarding pain, functionality and psychosocial factors.
Ethics approval(s)

1. Approved 15/11/2021, Aretaieio Hospital (EKPA / Medical School), Research Ethics Committee (76 Vas. Sofias Str., Athens, 11528, Greece; +302107286128; bxeir@aretaieio.uoa.gr), ref: 377/15-11-2021

2. Approved 21/06/2023, Research Ethics Committee University of West Attica (Agiou Spyridonos 28, Aigaleo, 12243, Greece; +302105387294; ethics@uniwa.gr), ref: 52120/30-05-2023

ConditionChronic low back pain
InterventionParticipants will be randomly allocated into three treatment Groups. All treatment groups will receive two treatments in the first four weeks and one treatment in the following four weeks.

Group A (Acupuncture): Sixteen standardised acupuncture points will be used. Needling placement will follow the WHO (2008) guidelines on acupuncture point locations. The acupoints chosen are: Large Intestine 4 (LI4), Stomach 36 (ST36), Spleen 6 (Sp 6), Gallbladder 30 (GB30) and Bladder 23, 24, 25, 26 (Bl23, Bl24, Bl25, &Bl26). All acupoints will be used bilaterally and electroacupuncture will be used in the following parts: LI4- LI4, ST36 - ST36, BL23(R)- BL26(R) and BL23(L) - BL23(L). The electroacupuncture will be delivered with a Frequency of 2 Hz. Each treatment session will have a duration of 25 minutes

Group B (Acupuncture and stretching). In this group, all participants will receive the same acupuncture treatment as described in Group A and additionally, they will receive a stretching exercise programme. Stretching will involve the hamstrings, the quadriceps, the tensor fascia latte, the gastrocnemius, the piriformis, and the core flexor and extensor muscles. Specifically, the following stretching exercises will be used bilaterally when needed: double knee to chest, hamstring muscle stretching, piriformis muscle stretching, tensor fasciae latae stretching, cat-camel stretching, and calf stretching. All stretches will be performed under the supervision of a researcher (blinded to the experiment and any other treatments either offered in other groups or in this group) following the acupuncture treatment. All stretches will be performed three times, the duration of each stretch will be 30 seconds followed by a 30-second interval. Participants will be given a handout and will be asked to perform them once daily at their house.

Group C (Acupuncture and Qigong)
In this group, all participants will receive the same acupuncture treatment as described in Group A and additionally, they will receive a Qigong exercise programme. Specifically, a standardised version of the Baduanjin - Eight pieces of Brocade - Qigong routine will be used. The participants will have an exercise session under the supervision of a researcher (blinded to the experiment and any other treatments either offered in other groups or this group) following the acupuncture treatment. The duration of this exercise routine will be approximately 10 - 15 minutes. Participants will be given a handout and will be asked to perform them once daily at their house.
Intervention typeMixed
Primary outcome measurePain measured through the sensitivity to pressure stimuli using a digital algometer calculating pressure pain thresholds at baseline, and 8 and 22 weeks
Secondary outcome measuresThe following Secondary outcome measures are assessed at baseline, 8 weeks and 22 weeks, unless stated:
1. Functional impairment measured using the five-repetition sit-to-stand test
2. Pain in conjunction with its psychosocial properties measured using the Short Form McGill Pain Questionnaire
3. Patients subjective measurement of their condition measured using the Global Perceived Effect scale at 8 weeks and 22 weeks
4. Disability measured using the Roland Morris Disability Questionnaire
5. Kinesiophobia measured using the Fear-Avoidance Beliefs Questionnaire (FABQ)
6. Depression and anxiety measured using the Hospital Anxiety and Depression Scale (HADS)
7. Catastrophising measured using the Pain Catastrophising Scale (PCS)
8. Quality of life measured using the 12-item Short Form Survey (SF-12) questionnaire
9. Compliance measured using a log that the participants complete at 8 weeks and 22 weeks
10. Medications measured using data recorded in a log
Overall study start date01/01/2020
Overall study end date01/12/2025

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexBoth
Target number of participants60
Participant inclusion criteria1. Aged between 18-65 years old
2. Ability to provide consent, good knowledge of Greek
3. Low back pain lasting more than three months
4. Diagnosis of nonspecific chronic low back pain
5. Pain sensation on the VAS scale >5
Participant exclusion criteria1. Participation in an exercise program in the previous three months
2. Participation in a physiotherapy program in the previous three months
3. Pain due to malignancy
4. Spondyloarthritis
5. Rheumatoid arthritis
6. Pregnancy
7. Postpartum (Up to six months from birth)
8. Knee osteoarthritis
9. Cognitive disability
10. Red Flags (e.g. suspicion of fracture, malignancy, cauda equina syndrome, rapid decrease in muscle strength, etc.)
Recruitment start date03/03/2023
Recruitment end date15/01/2025

Locations

Countries of recruitment

  • Greece

Study participating centres

University of West Attica
Laboratory of Musculoskeletal Physiotherapy, Physiotherapy Department, 28 Ag. Spyridonos Str.
Athens
12243
Greece
Aretaieio Hospital
76 Vas. Sofias Str.
Athens
11528
Greece

Sponsor information

University of West Attica
University/education

Laboratory of Musculoskeletal Physiotherapy, Physiotherapy Department, 28 Agiou Spyridonos
Aigaleo
12243
Greece

Phone +30 210 538 7487
Email ggeorge@uniwa.gr
Website https://physiolab.uniwa.gr/
ROR logo "ROR" https://ror.org/00r2r5k05

Funders

Funder type

Other

Investigator initiated and funded

No information available

University of West Attica

No information available

Results and Publications

Intention to publish date01/12/2025
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a peer-reviewed journal
IPD sharing planIndividual participant data collected during the trial will be available after de-identification (text, tables, figures, and appendices), until the 31st of December 2027. Access will be granted to researchers who provide a methodologically sound proposal to achieve the aims of the approved proposal. Proposals should be directed to Mr. Spyridon Sotiropoulos (spiros_sotiropoylos@hotmail.com). Data requestors must sign a data access agreement to gain access. After this date, the data will not be applicable. During recruitment, patients are informed of the purposes of our study.
Upon acceptance and before baseline measurements, participants give their written informed consent (document in Greek). The ethics committee of the University of West Attica will have to co-sign the release of the data.

Editorial Notes

19/06/2024: Study's existence confirmed by the Research Ethics Committee University of West Attica.